Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$2.55M Sell
16,739
-1,486
-8% -$231K 0.73% 37
2016
Q1
$2.73M Sell
18,225
-1,889
-9% -$281K 0.8% 37
2015
Q4
$3.27M Sell
20,114
-1,363
-6% -$214K 0.91% 34
2015
Q3
$2.97M Buy
21,477
+694
+3% +$109K 0.78% 36
2015
Q2
$3.19M Buy
20,783
+2,542
+14% +$407K 0.72% 37
2015
Q1
$2.92M Buy
18,241
+888
+5% +$140K 0.64% 39
2014
Q4
$2.76M Sell
17,353
-337
-2% -$52.5K 0.59% 44
2014
Q3
$2.48M Sell
17,690
-2,055
-10% -$268K 0.52% 54
2014
Q2
$2.34M Buy
19,745
+909
+5% +$105K 0.48% 57
2014
Q1
$2.32M Buy
18,836
+92
+0.5% +$11.2K 0.46% 58
2013
Q4
$2.14M Buy
18,744
+545
+3% +$62K 0.41% 65
2013
Q3
$2.04M Buy
18,199
+860
+5% +$93.3K 0.43% 63
2013
Q2
$1.71M Buy
+17,339
New +$1.8M 0.36% 70

Other funds holding AMGN

First Niagara Bank's AMGN Position: Q2 2016 in Review

First Niagara Bank reduced its Amgen (AMGN) stake by 8.2% in Q2 2016, selling an estimated $231K and leaving 16,739 shares worth $2.55M. The position accounts for 0.73% of the portfolio, ranked #37.

First Niagara Bank first reported a position in AMGN in Q2 2013 and has held it in 13 quarters since. The position peaked at $3.27M in Q4 2015. 1,473 funds tracked by Wall St. Rank hold AMGN as of Q2 2016.

  • First Niagara Bank held 16,739 shares of Amgen worth $2.55M as of Q2 2016.
  • First Niagara Bank sold 1,486 Amgen shares in Q2 2016, an estimated $231K.
  • Amgen made up 0.73% of First Niagara Bank's portfolio in Q2 2016, its #37 holding.
  • First Niagara Bank first reported a position in Amgen in Q2 2013 and has held it in 13 quarters since.
  • First Niagara Bank's Amgen position peaked at $3.27M in Q4 2015.
  • 1,473 funds tracked by Wall St. Rank held Amgen as of Q2 2016.

Based on First Niagara Bank's 13F filing for Q2 2016, filed 25 Jul 2016.